PSG9 and breast cancer: Analysis of the Gene Expression Omnibus (GEO) dataset (GSE25066)40 revealed that PSG9 levels were upregulated in the basal‐like subtype of breast tumors, the most aggressive subtype of breast cancer with poor prognosis, compared to the nonbasal type ones (Figure S2B).